(Q34613459)

3 August 2017

The PET radioligand [11C]MePPEP binds reversibly and with high specific signal to cannabinoid CB1 receptors in nonhuman primate brain (English)

1 reference

3 August 2017

0 references

0 references

0 references

0 references

13

Christer Halldin

1 reference

3 August 2017

Fumihiko Yasuno

1

1 reference

3 August 2017

Amira K Brown

2

1 reference

3 August 2017

Sami S Zoghbi

3

1 reference

3 August 2017

Joseph H Krushinski

4

1 reference

3 August 2017

Eyassu Chernet

5

1 reference

3 August 2017

Johannes Tauscher

6

1 reference

3 August 2017

John M Schaus

7

1 reference

3 August 2017

Lee A Phebus

8

1 reference

3 August 2017

Amy K Chesterfield

9

1 reference

3 August 2017

Christian C Felder

10

1 reference

3 August 2017

Robert L Gladding

11

1 reference

3 August 2017

Jinsoo Hong

12

1 reference

3 August 2017

Victor W Pike

14

1 reference

3 August 2017

Robert B Innis

15

1 reference

3 August 2017

language of work or name

English

0 references

publication date

28 March 2007

1 reference

3 August 2017

Neuropsychopharmacology

1 reference

3 August 2017

33

1 reference

3 August 2017

2

1 reference

3 August 2017

259-269

1 reference

https://scigraph.springernature.com/pub.10.1038/sj.npp.1301402

3 August 2017

0 references

cites work

A new look at the statistical model identification

1 reference

https://api.crossref.org/works/10.1038%2FSJ.NPP.1301402

Evidence for novel cannabinoid receptors

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.NPP.1301402

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.NPP.1301402

PET studies in the primate brain and biodistribution in mice using (−)-5′-18F-Δ8-THC

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.NPP.1301402

Relationship between the inhibition constant (K1) and the concentration of inhibitor which causes 50 per cent inhibition (I50) of an enzymatic reaction

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.NPP.1301402

Evaluation of ultrafiltration for the free-fraction determination of single photon emission computed tomography (SPECT) radiotracers: beta-CIT, IBF, and iomazenil.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.NPP.1301402

123I-labeled AM251: a radioiodinated ligand which binds in vivo to mouse brain cannabinoid CB1 receptors.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.NPP.1301402

Rimonabant: a selective blocker of the cannabinoid CB1 receptors for the management of obesity, smoking cessation and cardiometabolic risk factors

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.NPP.1301402

In vivo imaging of the brain cannabinoid receptor

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.NPP.1301402

Effects of temporal sampling, glucose metabolic rates, and disruptions of the blood-brain barrier on the FDG model with and without a vascular compartment: studies in human brain tumors with PET.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.NPP.1301402

Cannabinoid receptor localization in brain

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.NPP.1301402

Characterisation of the rat cerebella CB1 receptor using SR141716A, a central cannabinoid receptor antagonist

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.NPP.1301402

International Union of Pharmacology. XXVII. Classification of cannabinoid receptors

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.NPP.1301402

Synthesis, structure-activity relationship, and evaluation of SR141716 analogues: development of central cannabinoid receptor ligands with lower lipophilicity.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.NPP.1301402

Endocannabinoids in appetite control and the treatment of obesity

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.NPP.1301402

SPECT quantification of [123I]iomazenil binding to benzodiazepine receptors in nonhuman primates: I. Kinetic modeling of single bolus experiments.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.NPP.1301402

Cannabinoid CB1 receptor antagonists as promising new medications for drug dependence.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.NPP.1301402

Biodistribution of [18F] SR144385 and [18F] SR147963: selective radioligands for positron emission tomographic studies of brain cannabinoid receptors.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.NPP.1301402

Carbon-11 labeled radioligands for imaging brain cannabinoid receptors

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.NPP.1301402

Increased drug delivery to the brain by P-glycoprotein inhibition

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.NPP.1301402

The cannabinoid agonist WIN55,212-2 suppresses opioid-induced emesis in ferrets

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.NPP.1301402

The neurobiology of cannabinoid analgesia

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.NPP.1301402

Template-based method for multiple volumes of interest of human brain PET images.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.NPP.1301402

Quantification of serotonin 5-HT1A receptors in monkey brain with [11C](R)-(-)-RWAY.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.NPP.1301402

Locomotor activity and occupancy of brain cannabinoid CB1 receptors by the antagonist/inverse agonist AM281

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.NPP.1301402

7 January 2021

Characterisation of the binding of [3H]WAY-100635, a novel 5-hydroxytryptamine1A receptor antagonist, to rat brain

1 reference

https://api.crossref.org/works/10.1038%2FSJ.NPP.1301402

7 January 2021

Saturation of striatal D(2) dopamine receptors by clozapine.

1 reference

https://api.crossref.org/works/10.1038%2FSJ.NPP.1301402

7 January 2021

Reversal of P-glycoprotein mediated multidrug resistance by novel anthranilamide derivatives

1 reference

https://api.crossref.org/works/10.1038%2FSJ.NPP.1301402

7 January 2021

P-glycoprotein in the blood-brain barrier of mice influences the brain penetration and pharmacological activity of many drugs

1 reference

https://api.crossref.org/works/10.1038%2FSJ.NPP.1301402

7 January 2021

Identifiers

DOI

10.1038/SJ.NPP.1301402

1 reference

Dimensions Publication ID

3 August 2017

0 references

1 reference